My ePortfolio Register   

Abstract | Full HTML Article | PDF ecancer 6 246 / DOI: 10.3332/ecancer.2012.246

Visions

Circulating microRNAs: next-generation biomarkers for early lung cancer detection

Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage nonsmall cell lung carcinomas with 80% accuracy.

Related articles

Research: Prognostic factors in early-stage ovarian cancer

Abstract | Full Article | PDF Published: 13 Jun 2013 / DOI: 10.3332/ecancer.2013.325

Case Report: Literature meta-analysis of zosteriform cutaneous metastases from melanoma and a clinico-histopathological report from India

Abstract | Full Article | PDF Published: 11 Jun 2013 / DOI: 10.3332/ecancer.2013.324

Case Report: A case of recurrent metastatic ameloblastoma and hypercalcaemia successfully treated with carboplatin and paclitaxel: long survival and prolonged stable disease

Abstract | Full Article | PDF Published: 04 Jun 2013 / DOI: 10.3332/ecancer.2013.323

Review: A clinical update on massive ovarian oedema – a pseudotumour?

Abstract | Full Article | PDF Published: 14 May 2013 / DOI: 10.3332/ecancer.2013.318

Case Report: Primary intraosseous squamous cell carcinoma arising from an odontogenic keratocyst: a case report and literature review

Abstract | Full Article | PDF Published: 09 May 2013 / DOI: 10.3332/ecancer.2013.316



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence